| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.21 | 0.0008 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |